Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-25 @ 3:48 AM
NCT ID:
NCT02167802
Eligibility Criteria:
Inclusion Criteria for retrospective inclusions:
* All children from 1 month to 15 years and 3 months admitted in pediatric resuscitation;
* Community with severe bacterial infection defined by a bacterial infection documented by the presence of a bacterium from a normally sterile site (pleural cerebrospinal fluid joint fluid, blood, bone biopsy ...), a positive urine culture on a sampling done in aseptic conditions accompanied by a febrile illness (eg pyelonephritis), or purpura fulminans in the absence of documentation.
Inclusion Criteria for prospective inclusions:
* The inclusion criteria DIABACT III will be expanded to include children 0-1 months.
* Parents and patient (if applicable) who signed the consent biocollection for participation in the substudy.
Exclusion Criteria:
* Nosocomial Infections as defined by the Ministry of Health in its January 2007 issue on nosocomial infections namely: Nosocomial infections are infections acquired in a healthcare facility. Infection is considered nosocomial if it was absent at the time of admission of the patient in the health facility. When the infectious status of the patient at admission is unknown, the infection is generally considered nosocomial if it occurs after a period of at least 48 hours of hospitalization or a period longer than the incubation period of the infection. In case of surgical site infection, the period commonly allowed is 30 days, or if it has been set in place a prosthesis or implant, a year after the intervention.
* Children with whooping cough, bronchiolitis or viral infections
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
15 Years
Study:
NCT02167802
Study Brief:
Protocol Section:
NCT02167802